Browsing Category
Medicine
Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval
Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of!-->…
FDA Accepts Pfizer’s Supplemental New Drug Applications for BRAFTOVI + MEKTOVI
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Applications (sNDAs) for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) for patients with!-->…
PM Narendra Modi shares a thread on the impact of new AIIMS
The Prime Minister,Shri Narendra Modi has shared a tweet thread by Union Minister of State, Shri Nisith Pramanik which cites the example of West Bengal, this thread highlights the benefits that come with more AIIMS across India.
The…
Ministry of Health and Family Welfare shares latest Covid-19 Update
220.66 cr Total Vaccine doses (95.21 cr Second Dose and 22.86 cr Precaution Dose) have been administered so far under Nationwide Vaccination Drive9,981 doses administered in last 24 hoursIndia's Active caseload currently stands at!-->…
CME on Head Injury Management Held at Amrita Hospital, Faridabad
FARIDABAD : It is important to increase awareness about prevention of head injuries among people as it is the main cause of death in accidents, with India known as the head injuries capital of the world due to high number of road…
Middle Eastern woman with gigantic breasts undergoes surgery at Amrita Hospital, Faridabad
FARIDABAD : A 23-year-old woman from Middle East, in the prime of her youth, was in great distress because of her giant breast size which was induced due to her pregnancy. Due to a rare condition, her breasts had grown extremely…
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate
Pfizer Inc. (NYSE: PFE) today announced positive top-line results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene elaparvovec, an investigational gene therapy, for the treatment of adult males with moderately!-->…
Bharat Biotech’s nasal vaccine ‘iNCOVACC’ to be available at Rs 325 for govt…
Bharat Biotech has said that its nasal vaccine against Covid-19, iNCOVACC, would be available to the public from the fourth week of January. The Hyderabad-based biotechnology company said that the vaccine will cost 800 rupees for private…
Pfizer: U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s…
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review a Biologics License Application (BLA) for its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or!-->…
Pfizer: Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg!-->…